![Julien Dodet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julien Dodet
Amministratore Delegato presso Orano Med LLC
Posizioni attive di Julien Dodet
Società | Posizione | Inizio | Fine |
---|---|---|---|
Orano Med LLC
![]() Orano Med LLC Medical SpecialtiesHealth Technology Orano Med LLC develops targeted cancer therapies using lead-212 (212Pb). The company is based in Bethesda, MD. The company is ultimately controlled by the Government of France. The CEO of the company is Julien Dodet. | Amministratore Delegato | - | - |
Presidente | - | - | |
Orano Cycle SA
![]() Orano Cycle SA Other Metals/MineralsNon-Energy Minerals Orano Cycle SA provides nuclear fuel cycle services. It specializes in uranium mining conversion and enrichment. The company is headquartered in Chatillon, France. | Direttore/Membro del Consiglio | 14/12/2019 | - |
Orano Med SAS
![]() Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Presidente | - | - |
Storia della carriera di Julien Dodet
Statistiche
Distribuzione geografica
Francia | 3 |
Stati Uniti | 2 |
Posizioni
Chief Executive Officer | 2 |
President | 2 |
Director/Board Member | 2 |
Settori
Health Technology | 3 |
Non-Energy Minerals | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Orano Cycle SA
![]() Orano Cycle SA Other Metals/MineralsNon-Energy Minerals Orano Cycle SA provides nuclear fuel cycle services. It specializes in uranium mining conversion and enrichment. The company is headquartered in Chatillon, France. | Non-Energy Minerals |
Orano Med LLC
![]() Orano Med LLC Medical SpecialtiesHealth Technology Orano Med LLC develops targeted cancer therapies using lead-212 (212Pb). The company is based in Bethesda, MD. The company is ultimately controlled by the Government of France. The CEO of the company is Julien Dodet. | Health Technology |
Orano Med SAS
![]() Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Health Technology |
- Borsa valori
- Insiders
- Julien Dodet
- Esperienza